» Sur le Web » Clinical Trials News From Medical News Today
 
vendredi 21 septembre 2018

 
 

Clinical Trials News From Medical News Today
 

Latest Clinical Trials News From Medical News Today.

Les derniers articles du site :
 
DAYTRANA (methylphenidate Transdermal System) Significant Reduces ADHD Symptoms
Philadelphia, US - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its methylphenidate transdermal system (MTS), DAYTRANA TM demonstrated statistically significant reductions in the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and was generally well tolerated in (...)
jeudi 25 mai 2006
 
Drinking Mineral Water Could Reduce Aluminium In Alzheimer's Disease Sufferers
Scientists at Keele University in Staffordshire have found that drinking a well-known mineral water regularly could reduce the levels of aluminium in the bodies of people with Alzheimer's disease. Ten individuals with Alzheimer's were asked to drink up to 1.5L per day of the mineral water, (...)
jeudi 25 mai 2006
 
New Genetic Test For Breast Cancer
Researchers at Montefiore Medical Center are leading a nationwide clinical trial to determine whether a new genetic test can be used to personalize treatment for early-stage breast cancer. [click link for full article]
mercredi 24 mai 2006
 
Alcohol Abuse Increases The Risk Of Suffering From Pneumonia
The results of a paper published in the journal Chest (1) show that alcoholic and ex-alcoholic individuals have a higher risk of suffering from community acquired pneumonia. Although mortality did not differ significantly, an increase of the severeness of the disease was shown, and (...)
mercredi 24 mai 2006
 
InterMune Presents Preclinical Data For Actimmune(R) And Pirfenidone At American Thoracic Society Conference
InterMune, Inc. (Nasdaq:ITMN) announced today the presentation of preclinical study resultsinvolving its two Phase III drug candidates for idiopathic pulmonaryfibrosis (IPF), Actimmune(R) (interferon gamma-1b) and pirfenidone, at ATS2006, the annual International Conference of the American (...)
mardi 23 mai 2006
 
Positive Preliminary Results From A Phase 2a Clinical Trial Of XP19986 As A Treatment For Gastroesophageal Reflux Disease
SANTA CLARA, Calif., May 22 /PRNewswire-FirstCall/ -- XenoPort, Inc.(Nasdaq: XNPT) announced today preliminary top-line results of a Phase 2aclinical trial indicating that single doses of XP19986 were well toleratedand produced statistically significant reductions in the number of (...)
mardi 23 mai 2006
 
FDA Clearance Under A Special Protocol Assessment To Initiate CoFactor Phase III Clinical Trial
ADVENTRX Pharmaceuticals,Inc. (Amex: ANX) announced today that it reached an agreement under aspecial protocol assessment (SPA) with the US Food and Drug Administration(FDA) on the design of the Company's CoFactor(R) Phase III clinical trialprotocol. The Company also announced it remains on (...)
mardi 23 mai 2006
 
New Study Shows Erosive Esophagitis Healing Linked To Gastric Acid Control
New clinical datademonstrated, for the first time, in a prospective study, a directrelationship between controlling gastric (or stomach) acid and healingerosive esophagitis caused by acid reflux disease. The results of thetrial, which included more than 100 patients treated with (...)
mardi 23 mai 2006
 
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
A new clinical studyshows that the proton pump inhibitor (PPI) NEXIUM(R) (esomeprazolemagnesium) maintained normal gastric (stomach) acid levels in patients withZollinger- Ellison syndrome or idiopathic gastric acid hypersecretion(IGH). Results of the 12-month, multicenter study were presented (...)
mardi 23 mai 2006
 
Industry Supports Move Towards Increased Clinical Trial Transparency To Help Doctors & Patients To Facilitate Informed Treatment Choices
On the occasion of the International Clinical Trials Day Workshop, organized by the European Clinical Research Infrastructures Network (ECRIN) under the auspices of the European Commission and in collaboration with the WHO, the IFPMA reaffirms its support for enhancing clinical trial (...)
lundi 22 mai 2006
 
Accueil     |    Plan du site     |    Espace rédacteurs     |    Se connecter
  Mis à jour le vendredi 7 septembre 2018